advertisement
Haidich AB 13
Showing records 1 to 13 | Display all abstracts from Haidich AB79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Konstas AG
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78416 MicroRNA-related polymorphisms in pseudoexfoliation syndrome, pseudoexfoliative glaucoma, and primary open-angle glaucoma
Chatzikyriakidou A; Founti P
Ophthalmic Genetics 2018; 39: 603-609
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Katsanos A; Athanasopoulos GP; Athanasopoulos GP
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78416 MicroRNA-related polymorphisms in pseudoexfoliation syndrome, pseudoexfoliative glaucoma, and primary open-angle glaucoma
Melidou A; Minti F
Ophthalmic Genetics 2018; 39: 603-609
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Voudouragkaki IC; Panagiotou ES
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78416 MicroRNA-related polymorphisms in pseudoexfoliation syndrome, pseudoexfoliative glaucoma, and primary open-angle glaucoma
Bouras E; Anastasopoulos E
Ophthalmic Genetics 2018; 39: 603-609
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Pagkalidou E; Haidich AB
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78416 MicroRNA-related polymorphisms in pseudoexfoliation syndrome, pseudoexfoliative glaucoma, and primary open-angle glaucoma
Pappas T
Ophthalmic Genetics 2018; 39: 603-609
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Giannoulis DA
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78416 MicroRNA-related polymorphisms in pseudoexfoliation syndrome, pseudoexfoliative glaucoma, and primary open-angle glaucoma
Haidich AB
Ophthalmic Genetics 2018; 39: 603-609
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Spathi E
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78416 MicroRNA-related polymorphisms in pseudoexfoliation syndrome, pseudoexfoliative glaucoma, and primary open-angle glaucoma
Lambropoulos A; Topouzis F
Ophthalmic Genetics 2018; 39: 603-609
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Giannopoulos T; Katz LJ
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
